Removal of ventilator breathing tube is delayed for some patients, posing health risks

Spontaneous breathing trials were examined to study the issue further

11:46 AM

Author | Kelly Malcom

breathing tube in patient close up in hospital bed
Getty Images

Research from the University of Michigan Medical School finds that one in three hospitalized patients remain connected to a breathing tube after passing a spontaneous breathing trial.

While a delay in removal is sometimes necessary, being connected to a breathing tube increases the risk for ventilator-associated complications.

Patients are often intubated prior to surgery or during emergencies as a life saving measure to protect their airways and facilitate breathing. Yet, intubation also increases the risk of pneumonia, lung injury and prolonged sedation.

Spontaneous breathing trials are a guideline-recommended method that help determine whether a patient can breathe on their own following mechanical ventilation.

During an SBT, ventilator settings are minimized for a period of 30 minutes to three hours to see whether a patient’s heart rate and breathing are stable.

The U-M team, led by Anna Barker, M.D., Ph.D., and Michael Sjoding, M.D., from the Division of Pulmonary and Critical Care Medicine, sought to determine how many patients who pass this trial are extubated within six hours and what factors were associated with staying connected to the ventilator.

Analyzing electronic health record data from more than 3,000 patients between 2015 and 2023, they found that 62.3% of patients were extubated within six hours following a successful SBT.

Patients who weren't extubated spent an average of two additional days on the ventilator.

While some of the factors associated with remaining on the ventilator are known barriers to safe extubation, including having low levels of consciousness, being on low or high vasopressors (medications to raise blood pressure), or having a procedure within the day following the trial, more than half of patients had none of these factors.

For that group, the most common reason provided for non-removal was attending preference, which needs more research to better understand.

“These results highlight the importance of close communication between respiratory therapists, nurses and physicians when determining the safest time to extubate patients. The presence of families and caregivers help many patients stay more alert, which we also found is an important predictor of timely extubation after passing an SBT,” said Barker.

Additional authors: Rachel K. Hechtman and Megan Acho

Funding: This study was supported by the National Institutes of Health grants R01 HL 158626 and T32 HL 00774.

Paper cited: “Providers Consistently Delay Extubation After Successful Spontaneous Breathing Trials: A Retrospective Cohort Study,” Annals of the American Thoracic Society. DOI: 10.1513/AnnalsATS.202502-188OC 


More Articles About:

Pulmonology Injury Prevention Lungs and Breathing Breathing Device All Research Topics
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

Anna K. Barker

Anna K Barker, MD, PhD

Clinical Instructor

SJODING_Michael4x5.jpg

Michael William Sjoding, MD, MSc

Associate Professor

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Perforin increases endosomal-mitochondrial contact sites in tumor cells. Left is without perforin; right has perforin.
Health Lab

Immune system protein is a cancer killer on its own, new study shows

New study finds perforin can kill cancer tumor cells even when major granzymes were missing.
Portrait of Peter Mourani, M.D., Professor and Associate Chair of Research for the Department of Pediatrics and Division Director of Pediatric Critical Care Medicine at Michigan Medicine and U-M Health C.S. Mott Children's Hospital.
News Release

U-M-led consortium to receive up to $52 million in NIH funding to study why viral respiratory infections affect children differently

A Michigan Medicine-led research consortium has secured approval for up to $52 million in federal funding to launch a multicenter study examining why some young children recover fully from viral lower respiratory tract infections while others develop severe illness or lasting problems such as asthma.
pattern up close sequencing gene navy yellow
Health Lab

Comprehensive DNA sequencing reveals hidden drivers of cancer

Two research papers describe how long-read nanopore sequencing can detect alterations in cancer cells that might be missed by conventional sequencing.
cancer cell blue yellow
Health Lab

‘Molecular glue’ stabilizes protein that inhibits development of non-small cell lung cancer and uterine cancer

University of Michigan researchers found a new protein target PP2A and developed a drug to treat non-small cell lung cancers that have KRAS mutations.
Two older women looking at the Medicare website on a laptop screen
Health Lab

Many older adults make Medicare decisions quickly and most don’t change plans, poll finds

Sixty percent of older adults spend less than an hour choosing their Medicare coverage during Open Enrollment, a new poll finds.
pills close up some powder some round some long
Health Lab

What’s the latest on 7-OH and kratom availability and addiction care?

The United States Drug Enforcement Agency has announced it will place non-botanical products containing 7-OH on Schedule I, joining three other synthetic opioids, effectively removing them the market, leaving natural leaf kratom available amid a shortage of addiction treatment providers.